Spectral Medical Inc. (OTCMKTS:EDTXF) Sees Significant Growth in Short Interest

Spectral Medical Inc. (OTCMKTS:EDTXFGet Free Report) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 86,600 shares, an increase of 12.3% from the May 31st total of 77,100 shares. Based on an average daily volume of 10,700 shares, the days-to-cover ratio is presently 8.1 days.

Spectral Medical Trading Up 7.6 %

OTCMKTS:EDTXF traded up $0.03 during trading hours on Tuesday, hitting $0.38. 8,000 shares of the company traded hands, compared to its average volume of 7,163. The stock has a market capitalization of $106.40 million, a price-to-earnings ratio of -7.59 and a beta of 0.93. Spectral Medical has a twelve month low of $0.22 and a twelve month high of $0.50. The firm has a 50-day moving average of $0.36 and a 200 day moving average of $0.36.

Spectral Medical (OTCMKTS:EDTXFGet Free Report) last issued its quarterly earnings results on Monday, May 13th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.50 million for the quarter.

About Spectral Medical

(Get Free Report)

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.

Featured Articles

Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.